Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence

Table 6 Survival estimation according to the presence of each of the independent mortality risk factors

RT inscription MELD > 25	Genotype 1	RT donor age > 60 yr	No antiviral treatment post-RT	HCV viremia pre-RT	Number of factors	Survival
						1 yr	3 yr	5 yr
-	-	-	-	-	0	99.7%	99.5%	99.3%
+	-	-	-	-	1	99.1%	98.7%	98.3%
-	+	-	-	-		98.8%	98.1%	97.2%
-	-	+	-	-		99.0%	97.9%	97.0%
-	-	-	+	-		98.6%	97.7%	96.8%
-	-	-	-	+		98.0%	96.2%	94.8%
+	+	-	-	-	2	97.4%	95.3%	94.6%
+	-	+	-	-		97.7%	95.9%	94.3%
+	-	-	+	-		96.9%	95.1%	93.2%
-	+	+	-	-		96.0%	93.4%	90.8%
+	-	-	-	+		95.3%	91.7%	88.3%
-	+	-	+	-		94.8%	91.3%	87.9%
-	-	+	+	-		94.8%	90.7%	87.3%
-	+	-	-	+		91.3%	85.9%	81.0%
-	-	+	-	+		91.3%	85.7%	79.6%
-	-	-	+	+		87.0%	79.4%	71.2%
+	+	+	-	-	3	92.3%	87.8%	83.2%
+	+	-	+	-		89.4%	82.5%	76.4%
+	+	-	-	+		83.2%	73.1%1	63.9%
+	-	+	-	+		82.5%	72.1%	63.1%
-	+	+	+	-		82.0%	71.2%	61.9%
+	-	-	+	+		75.2%	61.4%	50.3%
+	-	+	+	-		72.5%	58.1%	47.0%
-	+	+	-	+		71.1%	56.3%	44.5%
-	+	-	+	+		61.2%	42.7%	30.2%
-	-	+	+	+		59.9%	41.6%	28.5%
+	+	+	+	-	4	67.2%	50.5%	37.9%
+	+	+	-	+		52.0%	32.4%	20.1%
+	+	-	+	+		36.9%	18.1%1	8.9%
+	-	+	+	+		35.7%	17.1%	8.3%
-	+	+	+	+		17.0%	4.5%	1.5%
+	+	+	+	+	5	2.8%	0.3%	0.0%

¹Two situations that underline the importance of HCV therapy after reLT. HCV: Hepatitis C virus; MELD: Model for End-stage Liver Disease.